ALVAL — Valbiotis SA Cashflow Statement
0.000.00%
- €18.96m
- €13.10m
- €0.18m
Annual cashflow statement for Valbiotis SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -3.83 | -8.68 | -12.3 | -7.37 | -10 |
Depreciation | |||||
Non-Cash Items | 0.712 | 1.45 | 2.32 | 0.591 | 0.825 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 4.77 | -0.863 | -0.053 | -2.01 | -2.92 |
Change in Accounts Receivable | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 2.69 | -7.16 | -9.19 | -8.05 | -11.5 |
Capital Expenditures | -0.331 | -0.421 | -0.288 | -0.247 | -0.261 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -0.001 | 0.414 | 0.091 | -0.003 | 0.2 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.332 | -0.007 | -0.197 | -0.25 | -0.061 |
Financing Cash Flow Items | -0.001 | — | — | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 4.19 | 14.4 | 8.4 | 12.5 | -1.84 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 6.55 | 7.24 | -0.988 | 4.19 | -13.4 |